The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Noriyuki Mori

Department of Medical Oncology

Division of Thoracic Oncology

Tochigi Cancer Center

Utsunomiya

Japan

[email]@*.*.tochigi.jp

Name/email consistency: medium

 
 
 
 
 
 
 

Affiliations

  • Department of Medical Oncology, Division of Thoracic Oncology, Tochigi Cancer Center, Utsunomiya, Japan. 2009
  • Department of Thoracic Diseases, Tochigi Cancer Center, 4-9-13, Yonan, Japan. 2003 - 2009

References

  1. A phase II trial of weekly chemotherapy with paclitaxel plus gemcitabine as a first-line treatment in advanced non-small-cell lung cancer. Mori, K., Kobayashi, H., Kamiyama, Y., Kano, Y., Kodama, T. Cancer Chemother. Pharmacol. (2009) [Pubmed]
  2. Phase II study of weekly chemotherapy with paclitaxel and gemcitabine as second-line treatment for advanced non-small cell lung cancer after treatment with platinum-based chemotherapy. Mori, K., Kamiyama, Y., Kondo, T., Kano, Y., Kodama, T. Cancer Chemother. Pharmacol. (2007) [Pubmed]
  3. Pilot phase II study of weekly chemotherapy with paclitaxel and carboplatin for refractory or relapsed small-cell lung cancer. Mori, K., Kamiyama, Y., Kondo, T., Kano, Y., Kodama, T. Cancer Chemother. Pharmacol. (2006) [Pubmed]
  4. Development of a novel computer-aided diagnosis system for automatic discrimination of malignant from benign solitary pulmonary nodules on thin-section dynamic computed tomography. Mori, K., Niki, N., Kondo, T., Kamiyama, Y., Kodama, T., Kawada, Y., Moriyama, N. J. Comput. Assist. Tomogr (2005) [Pubmed]
  5. A phase II study of docetaxel and infusional cisplatin in advanced non-small-cell lung cancer. Mori, K., Kamiyama, Y., Kondo, T., Kano, Y., Kodama, T. Chemotherapy (2005) [Pubmed]
  6. Phase II study of the combination of vinorelbine and cisplatin in advanced non-small-cell lung cancer. Mori, K., Kamiyama, Y., Kondo, T., Kano, Y., Tominaga, K. Cancer Chemother. Pharmacol. (2004) [Pubmed]
  7. Preventive effect of Kampo medicine (Hangeshashin-to) against irinotecan-induced diarrhea in advanced non-small-cell lung cancer. Mori, K., Kondo, T., Kamiyama, Y., Kano, Y., Tominaga, K. Cancer Chemother. Pharmacol. (2003) [Pubmed]
 
WikiGenes - Universities